184 related articles for article (PubMed ID: 37859330)
21. miRNAs in Alzheimer Disease - A Therapeutic Perspective.
Gupta P; Bhattacharjee S; Sharma AR; Sharma G; Lee SS; Chakraborty C
Curr Alzheimer Res; 2017; 14(11):1198-1206. PubMed ID: 28847283
[TBL] [Abstract][Full Text] [Related]
22. Differential blood miRNA expression in brain amyloid imaging-defined Alzheimer's disease and controls.
Wu HZY; Thalamuthu A; Cheng L; Fowler C; Masters CL; Sachdev P; Mather KA;
Alzheimers Res Ther; 2020 May; 12(1):59. PubMed ID: 32414413
[TBL] [Abstract][Full Text] [Related]
23. Analysis of Micro-RNA Expression by qPCR on a Microfluidics Platform for Alzheimer's Disease Biomarker Discovery.
Takousis P
Methods Mol Biol; 2018; 1750():283-292. PubMed ID: 29512080
[TBL] [Abstract][Full Text] [Related]
24. A Systematic Review of MicroRNA Expression as Biomarker of Late-Onset Alzheimer's Disease.
Herrera-Espejo S; Santos-Zorrozua B; Álvarez-González P; Lopez-Lopez E; Garcia-Orad Á
Mol Neurobiol; 2019 Dec; 56(12):8376-8391. PubMed ID: 31240600
[TBL] [Abstract][Full Text] [Related]
25. Identification of age- and disease-related alterations in circulating miRNAs in a mouse model of Alzheimer's disease.
Garza-Manero S; Arias C; Bermúdez-Rattoni F; Vaca L; Zepeda A
Front Cell Neurosci; 2015; 9():53. PubMed ID: 25745387
[TBL] [Abstract][Full Text] [Related]
26. The hidden players: Shedding light on the significance of post-translational modifications and miRNAs in Alzheimer's disease development.
Singh R; Hussain J; Kaur A; Jamdare BG; Pathak D; Garg K; Kaur R; Shankar S; Sunkaria A
Ageing Res Rev; 2023 Sep; 90():102002. PubMed ID: 37423542
[TBL] [Abstract][Full Text] [Related]
27. MicroRNAs in Alzheimer's Disease: Diagnostic Markers or Therapeutic Agents?
Angelucci F; Cechova K; Valis M; Kuca K; Zhang B; Hort J
Front Pharmacol; 2019; 10():665. PubMed ID: 31275145
[TBL] [Abstract][Full Text] [Related]
28. Secretases-related miRNAs in Alzheimer's disease: new approach for biomarker discovery.
Hajjari SN; Mehdizadeh M; Sadigh-Eteghad S; Shanehbandi D; Teimourian S; Baradaran B
Neurol Sci; 2017 Nov; 38(11):1921-1926. PubMed ID: 28791490
[TBL] [Abstract][Full Text] [Related]
29. GH deficiency confers protective advantages against Alzheimer's disease through rescued miRNA expression profile in APP/PS1 mice.
Noureddine S; Saccon T; Rudeski-Rohr T; Gesing A; Mason JB; Schneider A; Dhabhi J; Puig KL; Rakoczy S; Brown-Borg HM; Masternak MM
Geroscience; 2022 Dec; 44(6):2885-2893. PubMed ID: 35900661
[TBL] [Abstract][Full Text] [Related]
30. Cerebral Amyloid Angiopathy, Alzheimer's Disease and MicroRNA: miRNA as Diagnostic Biomarkers and Potential Therapeutic Targets.
Weldon Furr J; Morales-Scheihing D; Manwani B; Lee J; McCullough LD
Neuromolecular Med; 2019 Dec; 21(4):369-390. PubMed ID: 31586276
[TBL] [Abstract][Full Text] [Related]
31. Up-regulated Pro-inflammatory MicroRNAs (miRNAs) in Alzheimer's disease (AD) and Age-Related Macular Degeneration (AMD).
Pogue AI; Lukiw WJ
Cell Mol Neurobiol; 2018 Jul; 38(5):1021-1031. PubMed ID: 29302837
[TBL] [Abstract][Full Text] [Related]
32. Differential expression of MicroRNAs in Alzheimer's disease: a systematic review and meta-analysis.
Yoon S; Kim SE; Ko Y; Jeong GH; Lee KH; Lee J; Solmi M; Jacob L; Smith L; Stickley A; Carvalho AF; Dragioti E; Kronbichler A; Koyanagi A; Hong SH; Thompson T; Oh H; Salazar de Pablo G; Radua J; Shin JI; Fusar-Poli P
Mol Psychiatry; 2022 May; 27(5):2405-2413. PubMed ID: 35264731
[TBL] [Abstract][Full Text] [Related]
33. Profile of 6 microRNA in blood plasma distinguish early stage Alzheimer's disease patients from non-demented subjects.
Nagaraj S; Laskowska-Kaszub K; Dębski KJ; Wojsiat J; Dąbrowski M; Gabryelewicz T; Kuźnicki J; Wojda U
Oncotarget; 2017 Mar; 8(10):16122-16143. PubMed ID: 28179587
[TBL] [Abstract][Full Text] [Related]
34. Epigenetic Peripheral Biomarkers for Early Diagnosis of Alzheimer's Disease.
Villa C; Stoccoro A
Genes (Basel); 2022 Jul; 13(8):. PubMed ID: 35893045
[TBL] [Abstract][Full Text] [Related]
35. Dissecting the role of non-coding RNAs in the accumulation of amyloid and tau neuropathologies in Alzheimer's disease.
Patrick E; Rajagopal S; Wong HA; McCabe C; Xu J; Tang A; Imboywa SH; Schneider JA; Pochet N; Krichevsky AM; Chibnik LB; Bennett DA; De Jager PL
Mol Neurodegener; 2017 Jul; 12(1):51. PubMed ID: 28668092
[TBL] [Abstract][Full Text] [Related]
36. Cerebrospinal fluid microRNAs as potential biomarkers in Alzheimer's disease.
Noor Eddin A; Hamsho K; Adi G; Al-Rimawi M; Alfuwais M; Abdul Rab S; Alkattan K; Yaqinuddin A
Front Aging Neurosci; 2023; 15():1210191. PubMed ID: 37476007
[TBL] [Abstract][Full Text] [Related]
37. MicroRNAs in Human Cerebrospinal Fluid as Biomarkers for Alzheimer's Disease.
Lusardi TA; Phillips JI; Wiedrick JT; Harrington CA; Lind B; Lapidus JA; Quinn JF; Saugstad JA
J Alzheimers Dis; 2017; 55(3):1223-1233. PubMed ID: 27814298
[TBL] [Abstract][Full Text] [Related]
38. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
Jack CR; Bennett DA; Blennow K; Carrillo MC; Dunn B; Haeberlein SB; Holtzman DM; Jagust W; Jessen F; Karlawish J; Liu E; Molinuevo JL; Montine T; Phelps C; Rankin KP; Rowe CC; Scheltens P; Siemers E; Snyder HM; Sperling R;
Alzheimers Dement; 2018 Apr; 14(4):535-562. PubMed ID: 29653606
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic and therapeutic biomarkers for Alzheimer's disease in human-derived platelets.
Min JW; Lee J; Mun HJ; Kim DH; Park BG; Yoon B; Ryu JH; Cho HJ
Genes Genomics; 2020 Dec; 42(12):1467-1475. PubMed ID: 33180258
[TBL] [Abstract][Full Text] [Related]
40. Bioinformatics analysis of differentially expressed genes and identification of an miRNA-mRNA network associated with entorhinal cortex and hippocampus in Alzheimer's disease.
Li H; Zou L; Shi J; Han X
Hereditas; 2021 Jul; 158(1):25. PubMed ID: 34243818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
